Video Experimental Relacionado
Updated: Sep 10, 2025
09:15
Electrochemiluminescence Assays for Human Islet Autoantibodies
Published on: March 23, 2018
15.6K
Exceso de mortalidad en pacientes con diabetes tipo 1 en Bélgica: un estudio poblacional
Christophe de Meester1, Ans Van Ginckel1, Irm Vinck1
1Belgian Health Care Knowledge Centre, Brussels, Belgium.
Diabetes research and clinical practice
|August 23, 2025
Resumen
Los adultos con diabetes tipo 1 (DT1) en Bélgica experimentan un riesgo de mortalidad moderadamente mayor, perdiendo aproximadamente 4 años de esperanza de vida. Si bien es menor que en estudios anteriores, esto pone de relieve la necesidad de un monitoreo continuo y mejores estrategias de manejo de la diabetes.
Área de la Ciencia:
- Endocrinología
- Salud pública
- Epidemiología
Sus antecedentes:
- Los avances tecnológicos en el tratamiento de la diabetes tipo 1 (DT1) tienen como objetivo reducir la mortalidad.
- La evaluación del exceso de mortalidad y la esperanza de vida (EL) en pacientes con DT1 es crucial para evaluar la eficacia de la atención.
Objetivo del estudio:
- Investigar el exceso de mortalidad y LE en pacientes adultos con DT1 en Bélgica en comparación con la población general.
- Analizar el impacto de las comorbilidades en la mortalidad y en la EM en la DT1.
Principales métodos:
- Análisis retrospectivo de pacientes en un programa multidisciplinario de cuidado de la diabetes (2017-2021).
- Identificación de las comorbilidades utilizando datos de salud y medicación.
- Cálculo de las tasas de mortalidad estándar y las tasas de mortalidad excesiva.
Principales resultados:
- Se identificaron 144.960 pacientes-año con 2057 muertes, lo que da una tasa de mortalidad excesiva de 3,2 muertes por cada 1000 pacientes-año.
- La insuficiencia renal fue la única comorbilidad que afectó significativamente a pacientes más jóvenes con DT1.
- Los pacientes con DT1 de entre 20 y 50 años experimentaron una pérdida estimada de 4 años en la esperanza de vida.
Conclusiones:
- Los pacientes con DT1 en Bélgica presentan un riesgo de mortalidad excesiva moderadamente mayor, aunque menor que el reportado en estudios anteriores.
- Los avances continuos en el tratamiento de la diabetes requieren un análisis continuo para monitorear las tendencias y reevaluar los riesgos de mortalidad.
- La investigación adicional es vital para rastrear las mejoras y abordar las disparidades persistentes de mortalidad en la diabetes tipo 1.
Videos de Conceptos Relacionados
01:22Diabetes Mellitus: Overview and Type I Subtype
3.2K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
3.2K
01:22Diabetes Mellitus: Type 2 and Gestational
2.9K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.9K
01:36Carbohydrate Metabolism
11.7K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
11.7K
01:15Diabetes: Symptoms, Diagnosis, and Complications
687
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
687
01:20Pathophysiology of Diabetes
1.2K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.2K
01:16Insulin: Dosing Regimen and Adverse Effects
257
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
257